Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents (Q73134073)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Varga JL

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

Trends in Endocrinology and Metabolism

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

383-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Photoaffinity cross-linking to the pituitary receptor for growth hormone-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Inhibition of Metastatic Behavior of Murine Osteosarcoma by Hypophysectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Insulin-like growth factors: the unrecognised oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Involvement of IGF-II in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900209-X

7 January 2021

10.1016/S1043-2760(99)00209-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542394%20AND%20SRC:MED&resulttype=core&format=json